Dr Reddys Laboratories RDY
NYSE RDY
$13.10 +0.03 (+0.23%)
As of: Oct 19, 2026 · 3:59 PM EDT

Dr Reddys Laboratories (RDY) Payables (2009 - 2026)

Updated

Dr Reddys Laboratories (RDY) reported Payables of $1.01 billion for the quarter ended Jun 30, 2026, up 13.5% from $886.15 million a year earlier but down 0.7% from the prior quarter.

Analysis

Dr Reddys Laboratories (RDY) Payables (2009 - 2026) Analysis & Trends

As of Mar 31, 2026, Dr Reddys Laboratories posted Payables of $986 million, up 14.4% from the prior year.

  • Payables has increased for three consecutive years, with a five-year compound annual growth rate of 9.0% (years ended Mar 2021 to Mar 2026).
  • By year, Payables came in at $862 million in the year ended Mar 31, 2025 (+64.5%), $524 million in the year ended Mar 31, 2024 (+27.2%), $412 million in the year ended Mar 31, 2023 (-40.6%) and $694 million in the year ended Mar 31, 2022 (+8.3%).
  • Five-year quarterly Payables spans a low of $411.59 million in the quarter ended Mar 31, 2023 and a high of $1.02 billion in the quarter ended Dec 31, 2025.
  • Year over year, Payables has now increased in each of the last 12 quarters, with growth averaging 40.1% over the last eight quarters.
  • The high point for year-over-year Payables in five years was the quarter ended Sep 30, 2024 (growth of 105.8%); the low point was the quarter ended Mar 31, 2023 (a decline of 41.2%).
  • Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $1.01 billion (quarter ended Mar 31, 2026), $1.02 billion (quarter ended Dec 31, 2025) and $933.26 million (quarter ended Sep 30, 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Payables (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 6.11 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 20.92 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 33.30 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 5.96 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 4.26 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 22.89 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 2.87 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 674.00 Mn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 7.03 Bn
10 Dr Reddys Laboratories 10.90 Bn 10.27 Bn 396.53 Mn 1.00 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.00 Bn
Mar 31, 2026 980.82 Mn
Dec 31, 2025 1.01 Bn
Sep 30, 2025 917.69 Mn
Jun 30, 2025 887.46 Mn
Mar 31, 2025 860.05 Mn
Dec 31, 2024 914.15 Mn
Sep 30, 2024 904.86 Mn
Jun 30, 2024 686.32 Mn
Mar 31, 2024 523.33 Mn
Dec 31, 2023 528.01 Mn
Sep 30, 2023 436.72 Mn
Jun 30, 2023 416.08 Mn
Mar 31, 2023 412.10 Mn
Dec 31, 2022 452.60 Mn
Sep 30, 2022 411.73 Mn
Jun 30, 2022 544.41 Mn
Mar 31, 2022 694.39 Mn
Dec 31, 2021 615.64 Mn
Sep 30, 2021 658.38 Mn
API Access

Dr Reddys Laboratories Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=payables&ticker=RDY&period=max&api_key=YOUR_API_KEY